PNV

0.38%

$2.64 polynovo limited

Hi GavThe direct sales approach is working well in USA.The...

First 175 Last

Share
Profile

Follow
bobgr

76 Posts.

9

07/03/22

13:09

Post #: 60030872
Share

Originally posted by gavncath: ↑

Dear Polynovians,

I mostly don't post on PNV threads as the banter is mind numbing. I've held PNV shares since 2005 (or the entity at the time that owned PNV early on). Despite the 'ups and downs' I'm a happy-ish holder.

Am I disappointed that since BTM was developed there has not been a second product such as hernia device developed/approved? Absolutely.

Am I disappointed that the sales traction for BTM hasn't hit what I thought it would for such a market disruptive product? Absolutely.

Why do I remain a happy-ish holder? Because the BTM product is sensational. It saves lives. It improves quality of life. It gets minimal infection and saves hospital time and money. The opportunity is huge. The margins are ridiculous.

What would I like to see? A few things. PNV is currently trying to do everything from R&D/manufacturing and extending through to hospital sales... a massive ask for a small company in worldwide markets. I'd love to see PNV recognise their core skill was (and should be) a R&D company. Yes distributors take a margin but margins are huge anyway. Distributors have sales people on the ground and know the market they sell into... I'd love to see that change worldwide. I'd then like the appointment of a CEO with R&D/Manufacturing/regulatory experience... ditch the sales, leave that to experts that have that as their core business. Novosorb is a sensational biodegradable substance, it can be 3D printed, the potential medical uses are endless... R&D investment returns will be offensively large. These thoughts take me back to the book "Good to Great" by Jim Collins... I think the board needs to consider what the "Core skill" PNV has and get laser focussed on that.

I'd also love to see is PNV putting some effort into investor relations... :-(

My final comment is on share price... wow. Sub $1 is astounding. I've just bought myself another wedge of shares at 98cents this morning. Dead cheap. The shorters have provided a sensational opportunity to buy up again... I really feel for holders who need to sell at these stupidly low prices!

Stay well.

Gav

Expand

Hi Gav
The direct sales approach is working well in USA.
The distributor model in Europe is very disappointing.
One thing I have learned is you want something done well, do it yourself.
At this stage of infancy PNV need to be in control.
Bob

PNV Price at posting: 96.0¢ Sentiment: Buy Disclosure: Held
18 Upvote

2 Great analysis

Reply

Top Stories

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

DEG

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

STK

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

The market's shrugged at China's stimulus measures all year. Why is this one different?

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

NAM

ACCC seeks Olam divestments before it can buy Namoi Cotton

ESR

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

The winners & losers on market if negative gearing were gone

KAL

KalGold rolls out detailed aeromagnetic survey across Pinjin project

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 73 more messages in this thread...

First 175 Last

Add PNV (ASX) to my watchlist

(20min delay)
Last $2.64		Change -0.010(0.38%)		Mkt cap ! $1.823B

Open	High	Low	Value	Volume
$2.62	$2.64	$2.58	$2.297M	877.0K

Buyers (Bids)

No.	Vol.	Price($)
2	2375	$2.62

Sellers (Offers)

Price($)	Vol.	No.
$2.64	3584	1

View Market Depth

No.	Vol.	Price($)
2	2375	2.620
2	21885	2.610
4	17044	2.600
2	15142	2.590
1	2218	2.580

Price($)	Vol.	No.
2.640	3584	1
2.650	60884	10
2.660	35091	4
2.670	33811	5
2.680	65311	7

Last trade - 16.10pm 27/09/2024 (20 minute delay)

PNV (ASX) Chart

Hi GavThe direct sales approach is working well in USA.The...

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

The market's shrugged at China's stimulus measures all year. Why is this one different?

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

ACCC seeks Olam divestments before it can buy Namoi Cotton

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

The winners & losers on market if negative gearing were gone

KalGold rolls out detailed aeromagnetic survey across Pinjin project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Hi GavThe direct sales approach is working well in USA.The...

Top Stories

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

The market's shrugged at China's stimulus measures all year. Why is this one different?

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

ACCC seeks Olam divestments before it can buy Namoi Cotton

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

The winners & losers on market if negative gearing were gone

KalGold rolls out detailed aeromagnetic survey across Pinjin project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News